Results 81 to 90 of about 57,339 (296)

IL-6 receptor inhibition by tocilizumab attenuated expression of C5a receptor 1 and 2 in non-ST-elevation myocardial infarction [PDF]

, 2018
Background: Elevated interleukin-6 (IL-6) and complement activation are associated with detrimental effects of inflammation in coronary artery disease (CAD). The complement anaphylatoxins C5a and C3a interact with their receptors; the highly inflammatory
Thor Ueland, Gregersen, Ida, Nilsson, Per, Barratt-Due, Andreas, Ekholt, Karin, Geir Ø. Andersen, Pål Aukrust (151370), Ueland, Thor, Ida Gregersen (452380), Ida Gregersen, Arne Yndestad (224387), Hilde L. Orrem, Bjørn Bendz, Lars Gullestad (224437), Bente Halvorsen (151367), Pål Aukrust, Geir Ø. Andersen (5740334), Tom E. Mollnes (402444), Bente Halvorsen, Mollnes, Tom Eirik, Ola Kleveland, Andreas Barratt-Due, Bjørn Bendz (5740328), Thor Ueland (307058), Wiseth, Rune, Per H. Nilsson, Karin Ekholt (5740322), Pischke, Søren Erik, Andersen, Geir Øystein, Lars Gullestad, Yndestad, Arne, Orrem, Hilde Lang, Kleveland, Ola, Gullestad, Lars, Terje Espevik, Damås, Jan Kristian, Bendz, Bjørn, Søren E. Pischke, Hilde L. Orrem (5740313), Arne Yndestad, Karin Ekholt, Ola Kleveland (5740319), Halvorsen, Bente, Per H. Nilsson (241107), Tom E. Mollnes, Espevik, Terje, Søren E. Pischke (5740316), Andreas Barratt-Due (5740337), Jan K. Damås, Terje Espevik (281944), Rune Wiseth (5740331), Rune Wiseth, Aukrust, Pål, Jan K. Damås (5740325)   +53 more
core   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Timing of Coronary Angiography After Successful Fibrinolytic Therapy in ST-Segment Elevated Myocardial Infarction

, 2019
Background: We aimed to compare outcomes of patients received successful fibrinolytic treatment (FT) for ST-segment elevated myocardial infarction (STEMI) and performed coronary angiography (CAG) within 24 -72 h or after 72 h. Methods: Between March 2013
Kilic, Salih, Turkoglu, Cuneyt
core   +1 more source

Clinical and Angiographic Characteristics, in Hospital and Short-Term Outcomes in Patients with ST Elevated Myocardial Infarction, Undergoing Primary Percutaneous Intervention

, 2023
Clinical and Angiographic Characteristics, in Hospital and Short-Term Outcomes in Patients with ST Elevated Myocardial Infarction, Undergoing Primary Percutaneous Intervention Abstract: Background: Acute myocardial infarction is considered one of the ...
Hazhar Saadullah Saeed, Rafid Fayadh Al-Aqeedi   +1 more
core   +1 more source

A Case Series of Ventricular Septal Rupture Post-myocardial Infarction in a Tertiary Hospital

Indian Journal of Clinical Cardiology
A rare mechanical consequence that can occur after an acute myocardial infarction, particularly in the current thrombolytic era, is ventricular septal rupture.
Balamurugan Natarajan, Arumugam Moongilapatti Angappamudali, Elamaran Chidambaram   +2 more
doaj   +1 more source

Non‐ST‐elevation myocardial infarction with the use of oxymetazoline nasal spray

Revista Portuguesa de Cardiologia (English Edition), 2014
Oxymetazoline is an alpha-1 adrenergic receptor agonist that is commonly used for nasal decongestion and is readily available without a prescription. We report the case of a 64-year-old woman who developed prolonged chest pain associated with elevation of cardiac biomarkers after using oxymetazoline.
Saurabh Rajpal, Liam A. Morris, Nuri I. Akkus   +2 more
openaire   +3 more sources

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Myocardial Infarction after Endoscopic Removal of Foreign Body

Case Reports in Cardiology, 2017
The development of cardiac complications during or after endoscopic procedures is rare. However, mortality from myocardial ischemia, particularly in the elderly population, is elevated.
Carola Maraboto, Florentino Lupercio, Ileana L. Piña   +2 more
doaj   +1 more source

Pheochromocytoma mimicking a non-ST elevation acute myocardial infarction

, 2009
We report a 57 year-old male patient admitted with a diagnosis of non-ST elevation acute myocardial infarction. He had suffered from chest pain, diaphoresis and intense asthenia for three days.
Musuraca, Gerardo; Division of Cardiology, S. Maria del Carmine Hospital, Rovereto (TN), Italy, Vergara, Giuseppe, Terraneo, Clotilde, Prati, Daniele, Centonze, Maurizio, Vaccarini, Chiara, Imperadore, Ferdinando   +6 more
core   +1 more source

Impact of type 2 diabetes mellitus on low-grade inflammation in patients with ST-elevated myocardial infarction. [PDF]

, 2023
Chronic low-grade inflammation has emerged as a hallmark of type 2 diabetes mellitus (T2DM), contributing significantly to the pathogenesis of various cardiovascular diseases, notably ST-elevated myocardial infarction (STEMI).
Vytryhovskiy, A.I., Koroliuk, V.D., Bielinskyi, M.V., Seredyuk, N.M.   +3 more
core